|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 280, Issue 51, 41928-41939, December 23, 2005
Reversible Inactivation of HIF-1 Prolyl Hydroxylases Allows Cell Metabolism to Control Basal HIF-1*
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
S. Sudarshan, C. Sourbier, H.-S. Kong, K. Block, V. A. V. Romero, Y. Yang, C. Galindo, M. Mollapour, B. Scroggins, N. Goode, et al. Fumarate Hydratase Deficiency in Renal Cancer Induces Glycolytic Addiction and Hypoxia-Inducible Transcription Factor 1{alpha} Stabilization by Glucose-Dependent Generation of Reactive Oxygen Species Mol. Cell. Biol., August 1, 2009; 29(15): 4080 - 4090. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Schultz, V. Murthy, J. B. Tatro, and D. Beasley Prolyl hydroxylase 2 deficiency limits proliferation of vascular smooth muscle cells by hypoxia-inducible factor-1{alpha}-dependent mechanisms Am J Physiol Lung Cell Mol Physiol, June 1, 2009; 296(6): L921 - L927. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Sun, S. Zhou, S. S. Chang, T. McFate, A. Verma, and J. A. Califano Mitochondrial Mutations Contribute to HIF1{alpha} Accumulation via Increased Reactive Oxygen Species and Up-regulated Pyruvate Dehydrogenease Kinase 2 in Head and Neck Squamous Cell Carcinoma Clin. Cancer Res., January 15, 2009; 15(2): 476 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Prentki and S. R. M. Madiraju Glycerolipid Metabolism and Signaling in Health and Disease Endocr. Rev., October 1, 2008; 29(6): 647 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Qutub and A. S. Popel Reactive Oxygen Species Regulate Hypoxia-Inducible Factor 1{alpha} Differentially in Cancer and Ischemia Mol. Cell. Biol., August 15, 2008; 28(16): 5106 - 5119. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. McFate, A. Mohyeldin, H. Lu, J. Thakar, J. Henriques, N. D. Halim, H. Wu, M. J. Schell, T. M. Tsang, O. Teahan, et al. Pyruvate Dehydrogenase Complex Activity Controls Metabolic and Malignant Phenotype in Cancer Cells J. Biol. Chem., August 15, 2008; 283(33): 22700 - 22708. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-K. Park, D.-R. Ahn, M. Oh, T. Lee, E. G. Yang, M. Son, and H. Park Nitric Oxide Donor, ({+/-})-S-Nitroso-N-acetylpenicillamine, Stabilizes Transactive Hypoxia-Inducible Factor-1{alpha} by Inhibiting von Hippel-Lindau Recruitment and Asparagine Hydroxylation Mol. Pharmacol., July 1, 2008; 74(1): 236 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bishop, D. Gallagher, A. Pascual, C. A. Lygate, J. P. de Bono, L. G. Nicholls, P. Ortega-Saenz, H. Oster, B. Wijeyekoon, A. I. Sutherland, et al. Abnormal Sympathoadrenal Development and Systemic Hypotension in PHD3-/- Mice Mol. Cell. Biol., May 15, 2008; 28(10): 3386 - 3400. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Semenza Hypoxia-Inducible Factor 1 (HIF-1) Pathway Sci. Signal., October 9, 2007; 2007(407): cm8 - cm8. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lamirand, G. Mercier, M. Ramauge, M. Pierre, and F. Courtin Hypoxia Stabilizes Type 2 Deiodinase Activity in Rat Astrocytes Endocrinology, October 1, 2007; 148(10): 4745 - 4753. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhou, S. Kachhap, W. Sun, G. Wu, A. Chuang, L. Poeta, L. Grumbine, S. K. Mithani, A. Chatterjee, W. Koch, et al. Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck PNAS, May 1, 2007; 104(18): 7540 - 7545. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Lum, T. Bui, M. Gruber, J. D. Gordan, R. J. DeBerardinis, K. L. Covello, M. C. Simon, and C. B. Thompson The transcription factor HIF-1{alpha} plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis Genes & Dev., May 1, 2007; 21(9): 1037 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Koivunen, M. Hirsila, A. M. Remes, I. E. Hassinen, K. I. Kivirikko, and J. Myllyharju Inhibition of Hypoxia-inducible Factor (HIF) Hydroxylases by Citric Acid Cycle Intermediates: POSSIBLE LINKS BETWEEN CELL METABOLISM AND STABILIZATION OF HIF J. Biol. Chem., February 16, 2007; 282(7): 4524 - 4532. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Hewitson, B. M. R. Lienard, M. A. McDonough, I. J. Clifton, D. Butler, A. S. Soares, N. J. Oldham, L. A. McNeill, and C. J. Schofield Structural and Mechanistic Studies on the Inhibition of the Hypoxia-inducible Transcription Factor Hydroxylases by Tricarboxylic Acid Cycle Intermediates J. Biol. Chem., February 2, 2007; 282(5): 3293 - 3301. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Pan, K. D. Mansfield, C. C. Bertozzi, V. Rudenko, D. A. Chan, A. J. Giaccia, and M. C. Simon Multiple Factors Affecting Cellular Redox Status and Energy Metabolism Modulate Hypoxia-Inducible Factor Prolyl Hydroxylase Activity In Vivo and In Vitro Mol. Cell. Biol., February 1, 2007; 27(3): 912 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Li, F. Yi, C. M. Sundy, L. Chen, M. L. Hilliker, D. K. Donley, D. B. Muldoon, and P.-L. Li Expression and actions of HIF prolyl-4-hydroxylase in the rat kidneys Am J Physiol Renal Physiol, January 1, 2007; 292(1): F207 - F216. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lopez-Lazaro Hypoxia-Inducible Factor 1 as a Possible Target for Cancer Chemoprevention Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2332 - 2335. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Koukourakis, A. Giatromanolaki, E. Sivridis, K. C. Gatter, and A. L. Harris Lactate Dehydrogenase 5 Expression in Operable Colorectal Cancer: Strong Association With Survival and Activated Vascular Endothelial Growth Factor Pathway--A Report of the Tumour Angiogenesis Research Group J. Clin. Oncol., September 10, 2006; 24(26): 4301 - 4308. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Acker, J. Fandrey, and H. Acker The good, the bad and the ugly in oxygen-sensing: ROS, cytochromes and prolyl-hydroxylases Cardiovasc Res, July 15, 2006; 71(2): 195 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Bi, Q. Lin, T. W. Foo, S. Joshi, T. You, H.-M. Shen, C. N. Ong, P. Y. Cheah, K. W. Eu, and C.-L. Hew Proteomic Analysis of Colorectal Cancer Reveals Alterations in Metabolic Pathways: Mechanism of Tumorigenesis Mol. Cell. Proteomics, June 1, 2006; 5(6): 1119 - 1130. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |